Resident Memory T Cells in Vitiligo

ASSESSMENT OF TRISTETRAPROLIN EXPRESSION IN LESIONAL SKIN OF PATIENTS WITH NON SEGMENTAL VITILIGO

NCT05990309 ·Status: UNKNOWN ·Phase: NA

Assessment of Hypoxia Inducible Factor and Autophagy Related Genes in Patients With Non-Segmental Vitiligo

NCT06410898 ·Status: RECRUITING ·Phase: NA

Assessment of Circulating Fubctional Mitochondrias in Vitiligo Patients

NCT05525741 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Evaluation of Serum Interleukin-15 and Interleukin-22 Levels in Patients With Non-segmental Vitiligo

NCT05121532 ·Status: UNKNOWN ·Phase: NA

A Study of the Safety and Tolerability of MEDI-551 in Scleroderma

NCT00946699 ·Status: COMPLETED ·Phase: PHASE1

Evaluation of Serum and Tissue Cathepsin L in Non-segmental Vitiligo Patients

NCT06261073 ·Status: NOT_YET_RECRUITING ·Phase: NA

Sensory Symptoms in Active Vitiligo

NCT05390164 ·Status: UNKNOWN

Leucotrichia in Vitiligo

NCT03402633 ·Status: COMPLETED

Building an Assessment Model for Vitiligo Activity and Prognosis Using Peripheral Blood Cytokine Profiles

NCT07298551 ·Status: NOT_YET_RECRUITING

The Investigation on the Expression of High Mobility Group Protein Box-1 (HMGB1) in Peripheral Blood of Vitiligo Patients and Healthy Controls According to Clinical Features, Treatment and Disease Activity

NCT03741738 ·Status: COMPLETED

Response to Tregs in Innate Immunity Receptor LRP1 (CD91) and Tregs in Periferic Blood Mononuclear Cells in Patients With Non-segmentary Vitiligo

NCT03249064 ·Status: COMPLETED

Cross-sectional Study to Characterize Real World Burden of Disease in Patients With Vitiligo in China

NCT07058051 ·Status: COMPLETED

ERASE VITILIGO Early Repigmentation Approach for Stopping the Evolution of VITILIGO Prospective Multicentric Interventional Study With Blinded Evaluation

NCT04843059 ·Status: COMPLETED ·Phase: NA

Analysis of Inflammation in the Vitiligo and Other Inflammatory Skin Diseases: Psoriasis, Atopic Dermatitis and Alopecia Areata

NCT03976622 ·Status: UNKNOWN

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

NCT06602232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1

Vitiligo Treatment by Targeting TYK2 Mediated Responses

NCT06327321 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Serum and Tissue Level of Interleukin-15 (IL-15) and IL-15 Receptor Alpha (IL-15Rα) in Mycosis Fungoides

NCT05526638 ·Status: UNKNOWN ·Phase: NA

Insulin Like Growth Factor-1 Against Oxidative Stress in Vitiligo

NCT05812079 ·Status: NOT_YET_RECRUITING

Autologous Non-cultured Epidermal Cell Suspension Transplantation in the Treatment of Vitiligo

NCT07187882 ·Status: RECRUITING ·Phase: NA

Janus Kinase 1 in Vitiligo & Psoriasis

NCT03762551 ·Status: COMPLETED ·Phase: NA

Deciphering the Vitiligo Transcriptomic Signature Between Repigmented and Non Repigmented Lesions

NCT05927272 ·Status: RECRUITING ·Phase: NA

A Pilot Cohort Study of Risk Factors and Novel Methods of Skin Lesion Assessments in Adults With Atopic Dermatitis, Alopecia Areata, Psoriasis or Vitiligo

NCT06319781 ·Status: RECRUITING

Evaluation of Human Melanocytes After the Use of PRP Versus Fractional CO2 Laser in Vitiligo

NCT04320160 ·Status: UNKNOWN ·Phase: NA

Establishing Fibroblast-Derived Cell Lines From Skin Biopsies of Patients With Immunodeficiency or Immunodysregulation Disorders

NCT00895271 ·Status: ENROLLING_BY_INVITATION

The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis

NCT00509314 ·Status: UNKNOWN